European Medicines Agency starts assessing the use of Moderna in children

The European Medicines Agency (EMA) has started to evaluate the application of the pharmaceutical company Moderna to extend the use of its vaccine to children between 6 and 11 years of age. In July, the green light was given for its use in teenagers.